These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 36275024)

  • 1. The evolving biology of
    Jones RM; Adams KN; Eldesouky HE; Sherman DR
    Front Cell Infect Microbiol; 2022; 12():1027394. PubMed ID: 36275024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in
    Eoh H; Liu R; Lim J; Lee JJ; Sell P
    Front Cell Infect Microbiol; 2022; 12():958240. PubMed ID: 36072228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance and tolerance of Mycobacterium tuberculosis to antimicrobial agents-How M. tuberculosis can escape antibiotics.
    Li H; Yuan J; Duan S; Pang Y
    WIREs Mech Dis; 2022 Nov; 14(6):e1573. PubMed ID: 35753313
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Stanley S; Liu Q; Fortune SM
    Front Cell Infect Microbiol; 2022; 12():1007958. PubMed ID: 36262182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the mechanisms of intrinsic drug resistance in
    Poulton NC; Rock JM
    Front Cell Infect Microbiol; 2022; 12():997283. PubMed ID: 36325467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates on drug resistance in Mycobacterium tuberculosis.
    Singh R; Dwivedi SP; Gaharwar US; Meena R; Rajamani P; Prasad T
    J Appl Microbiol; 2020 Jun; 128(6):1547-1567. PubMed ID: 31595643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
    Park HE; Lee W; Shin MK; Shin SJ
    Front Immunol; 2021; 12():703060. PubMed ID: 34262571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction: Novel insights into TB research and drug discovery.
    Grüber G
    Prog Biophys Mol Biol; 2020 May; 152():2-5. PubMed ID: 32087187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools to Alleviate the Drug Resistance in
    Rabaan AA; Mutair AA; Albayat H; Alotaibi J; Sulaiman T; Aljeldah M; Shammari BRA; Alfaraj AH; Al Fares MA; Alwarthan S; Binjomah AZ; Alzahrani MS; Alhani HM; Almogbel MS; Abuzaid AA; Alqurainees G; Al Ibrahim F; Alhaddad AH; Alfaresi M; Al-Baghli N; Alhumaid S
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting redox heterogeneity to counteract drug tolerance in replicating
    Mishra R; Kohli S; Malhotra N; Bandyopadhyay P; Mehta M; Munshi M; Adiga V; Ahuja VK; Shandil RK; Rajmani RS; Seshasayee ASN; Singh A
    Sci Transl Med; 2019 Nov; 11(518):. PubMed ID: 31723039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis.
    Craggs PD; de Carvalho LPS
    Curr Opin Microbiol; 2022 Oct; 69():102191. PubMed ID: 35970040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
    Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
    mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of
    Nimmo C; Millard J; Faulkner V; Monteserin J; Pugh H; Johnson EO
    Front Cell Infect Microbiol; 2022; 12():954074. PubMed ID: 36275027
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevalence and transmission of pyrazinamide-resistant
    Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging advances in identifying signal transmission molecules involved in the interaction between
    Wang Y; Shi Q; Chen Q; Zhou X; Yuan H; Jia X; Liu S; Li Q; Ge L
    Front Cell Infect Microbiol; 2022; 12():956311. PubMed ID: 35959378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.